认知功能障碍和精神分裂症的磷酸二酯酶靶点——纽约科学院会议
Phosphodiesterase Targets for Cognitive Dysfunction and Schizophrenia--a New York Academy of Sciences Meeting.
作者信息
Zhang Han Ting
机构信息
West Virginia University School of Medicine, One Medical Center Drive, PO Box 9137, Morgantown, WV 26506-9137, USA.
出版信息
IDrugs. 2010 Mar;13(3):166-8.
The Phosphodiesterase Targets for Cognitive Dysfunction and Schizophrenia meeting, held in New York, included topics covering new therapeutic developments in the field of PDE inhibitors for the treatment of cognitive dysfunction. This conference report highlights selected presentations on inhibitors of PDE1, PDE4, PDE5, PDE8, PDE9 and PDE10 for schizophrenia-related cognitive disorders. Investigational drugs discussed include PF-2545920 (Pfizer Inc).
在纽约召开的“认知功能障碍与精神分裂症的磷酸二酯酶靶点”会议涵盖了磷酸二酯酶（PDE）抑制剂治疗认知功能障碍领域新治疗进展的相关主题。本会议报告重点介绍了关于PDE1、PDE4、PDE5、PDE8、PDE9和PDE10抑制剂用于精神分裂症相关认知障碍的部分演讲内容。所讨论的在研药物包括PF-2545920（辉瑞公司）。
Zotero 插件